436 related articles for article (PubMed ID: 17637672)
1. Delayed ageing through damage protection by the Arf/p53 pathway.
Matheu A; Maraver A; Klatt P; Flores I; Garcia-Cao I; Borras C; Flores JM; Viña J; Blasco MA; Serrano M
Nature; 2007 Jul; 448(7151):375-9. PubMed ID: 17637672
[TBL] [Abstract][Full Text] [Related]
2. Anti-aging activity of the Ink4/Arf locus.
Matheu A; Maraver A; Collado M; Garcia-Cao I; Cañamero M; Borras C; Flores JM; Klatt P; Viña J; Serrano M
Aging Cell; 2009 Apr; 8(2):152-61. PubMed ID: 19239418
[TBL] [Abstract][Full Text] [Related]
3. The Arf/p53 pathway in cancer and aging.
Matheu A; Maraver A; Serrano M
Cancer Res; 2008 Aug; 68(15):6031-4. PubMed ID: 18676821
[TBL] [Abstract][Full Text] [Related]
4. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
5. Alternative reading frame protein (ARF)-independent function of CARF (collaborator of ARF) involves its interactions with p53: evidence for a novel p53-activation pathway and its negative feedback control.
Hasan MK; Yaguchi T; Minoda Y; Hirano T; Taira K; Wadhwa R; Kaul SC
Biochem J; 2004 Jun; 380(Pt 3):605-10. PubMed ID: 15109303
[TBL] [Abstract][Full Text] [Related]
6. p53 and ageing: too much of a good thing?
Kirkwood TB
Bioessays; 2002 Jul; 24(7):577-9. PubMed ID: 12111716
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
[TBL] [Abstract][Full Text] [Related]
8. When mutant p53 plays hide and seek: a new challenge for diagnosis and therapy?
Soussi T; Hjortsberg L
Trends Mol Med; 2009 Jan; 15(1):1-4. PubMed ID: 19097939
[TBL] [Abstract][Full Text] [Related]
9. p53 Deficiency leads to compensatory up-regulation of p16INK4a.
Leong WF; Chau JF; Li B
Mol Cancer Res; 2009 Mar; 7(3):354-60. PubMed ID: 19240179
[TBL] [Abstract][Full Text] [Related]
10. Small mitochondrial ARF (smARF) is located in both the nucleus and cytoplasm, induces cell death, and activates p53 in mouse fibroblasts.
Ueda Y; Koya T; Yoneda-Kato N; Kato JY
FEBS Lett; 2008 Apr; 582(10):1459-64. PubMed ID: 18381074
[TBL] [Abstract][Full Text] [Related]
11. p53 mutant mice that display early ageing-associated phenotypes.
Tyner SD; Venkatachalam S; Choi J; Jones S; Ghebranious N; Igelmann H; Lu X; Soron G; Cooper B; Brayton C; Park SH; Thompson T; Karsenty G; Bradley A; Donehower LA
Nature; 2002 Jan; 415(6867):45-53. PubMed ID: 11780111
[TBL] [Abstract][Full Text] [Related]
12. Physiological ageing: role of p53 and PARP-1 tumor suppressors in the regulation of terminal senescence.
Wesierska-Gadek J; Ranftler C; Schmid G
J Physiol Pharmacol; 2005 Mar; 56 Suppl 2():77-88. PubMed ID: 16077192
[TBL] [Abstract][Full Text] [Related]
13. Cancer biology: can less be more for p53?
Berns A
Nature; 2006 Sep; 443(7108):153-4. PubMed ID: 16971934
[No Abstract] [Full Text] [Related]
14. DNA damage-dependent translocation of B23 and p19 ARF is regulated by the Jun N-terminal kinase pathway.
Yogev O; Saadon K; Anzi S; Inoue K; Shaulian E
Cancer Res; 2008 Mar; 68(5):1398-406. PubMed ID: 18316603
[TBL] [Abstract][Full Text] [Related]
15. Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors.
Akala OO; Park IK; Qian D; Pihalja M; Becker MW; Clarke MF
Nature; 2008 May; 453(7192):228-32. PubMed ID: 18418377
[TBL] [Abstract][Full Text] [Related]
16. Polycomb complexes regulate cellular senescence by repression of ARF in cooperation with E2F3.
Miki J; Fujimura Y; Koseki H; Kamijo T
Genes Cells; 2007 Dec; 12(12):1371-82. PubMed ID: 18076574
[TBL] [Abstract][Full Text] [Related]
17. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression.
Christophorou MA; Ringshausen I; Finch AJ; Swigart LB; Evan GI
Nature; 2006 Sep; 443(7108):214-7. PubMed ID: 16957739
[TBL] [Abstract][Full Text] [Related]
18. The alternative reading frame tumor suppressor antagonizes hypoxia-induced cancer cell migration via interaction with the COOH-terminal binding protein corepressor.
Paliwal S; Kovi RC; Nath B; Chen YW; Lewis BC; Grossman SR
Cancer Res; 2007 Oct; 67(19):9322-9. PubMed ID: 17909040
[TBL] [Abstract][Full Text] [Related]
19. A spatially and temporally restricted mouse model of soft tissue sarcoma.
Kirsch DG; Dinulescu DM; Miller JB; Grimm J; Santiago PM; Young NP; Nielsen GP; Quade BJ; Chaber CJ; Schultz CP; Takeuchi O; Bronson RT; Crowley D; Korsmeyer SJ; Yoon SS; Hornicek FJ; Weissleder R; Jacks T
Nat Med; 2007 Aug; 13(8):992-7. PubMed ID: 17676052
[TBL] [Abstract][Full Text] [Related]
20. Increased gene dosage of Ink4/Arf and p53 delays age-associated central nervous system functional decline.
Carrasco-Garcia E; Arrizabalaga O; Serrano M; Lovell-Badge R; Matheu A
Aging Cell; 2015 Aug; 14(4):710-4. PubMed ID: 25990896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
